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 Abstract 
 
Background: Posterior urethral valves (PUV) result in a spectrum of obstruction, and up 
to thirty percent of patients progress to renal failure.  
Objective: Descriptive study of patients with PUV, and to compare growth and renal 
function in the primary valve ablation versus vesicostomy group. 
Methods: Retrospective record review of patients with PUV at Chris Hani Baragwanath 
Hospital from January 1985 to December 2005. 
Results: A total of 128 boys were identified. The mean (range) age was 12.9 months (0 to 
139.4). The mean duration of follow-up was 42 months, with 65% lost to follow- up. UTI 
and voiding problems were the most common modes of presentation. Young age at 
presentation and renal dysfunction after surgery were poor prognostic features. 
Hydronephrosis was present in 89.5%. Renal failure was present in 37% of patients at last 
visit. Primary valve ablation was performed in 44.2% and vesicostomy in 55.8%. No 
statistical difference in renal outcome or somatic growth was observed between the 
surgical groups.  
Conclusion: PUV is a common condition with significant morbidity. The renal outcome 
in black South African boys is similar to reports from developed countries. The type of 
initial surgical management did not impact on renal outcome or somatic growth. 
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CKD: chronic kidney disease 
DMSA: 99 technetium dimercaptosuccinic acid  
GFR: glomerular filtration rate 
PUV: posterior urethral valves 
UTI: urinary tract infection 
VCU: voiding cystourethrogram 
VUR: vesico- ureteric reflux 
VURD: valves with vesico- ureteric reflux and ipsilateral renal dysplasia 
 
 
 
 
 
 
 
 
 
 
                                                CHAPTER 1 
 
1.0 Introduction 
Posterior urethral valves (PUV) result from a congenital malformation of the male urethra 
at the junction of the membranous and penile urethra that causes obstruction to urinary 
flow ¹. It is estimated to affect 1:5000- 1:8000 male births ². The exact embryology of 
PUV formation remains in dispute ³, and genetic abnormalities have been explored 4. 
 
1.1 Diagnosis 
The diagnosis may be suspected on antenatal ultrasound in the presence of 
oligohydramnios, hydronephrosis and a dilated proximal urethra with a resultant 
“keyhole” sign, but this is not specific for PUV 5. The diagnosis must be confirmed after 
birth by voiding cystourethrogram (VCU), where the typical finding is that of a dilated 
posterior urethra with a trabeculated bladder 6 (Figure 1). Vesico-uretric reflux (VUR) 
may be present.  
                                                                                      
                                   Figure 1. VCU showing a dilated posterior urethra. No VUR is present.                                                            
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 The presence of PUV may also be confirmed at cystoscopy, when valves or remnants of  
valves are visible. 
 
1.2 Clinical presentation 
The clinical presentation of boys with PUV represents a spectrum of obstruction. Patients 
with severe obstruction present early in the neonatal period with Potters sequence of 
oligohydramnios: intra-uterine growth retardation, typical facies, pulmonary hypoplasia 
and renal dysfunction. They typically have hydronephrosis and a palpable walnut-shaped 
bladder. Patients with PUV may have ascites, metabolic acidosis, and/ or urosepsis 7, 8. 
Milder forms of obstruction present later, usually with urinary tract infection (UTI), poor 
urinary stream or urinary incontinence 9. 
 
1.3 Management options  
Fetal surgery for PUV includes vesico-amniotic shunting or cystoscopy and valve 
ablation 2. Theoretically, the relief of obstruction to urine flow should not only increase  
amniotic fluid volume to allow normal lung development, but it should also prevent renal 
dysfunction. However, in practice this is not the case 10, 11. This could reflect primary 
renal dysplasia associated with PUV. 
 
All patients with PUV are initially catheterized to overcome the obstruction, and 
carefully monitored for post- obstruction polyuria. Adequate intravenous fluid support is 
mandatory. Antibiotics are given if UTI or sepsis is suspected. Abnormalities of 
electrolytes and acidosis are corrected 12. 
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The current surgical treatment of PUV is primary valve ablation via trans-urethral 
cystoscopy 13. This procedure may be limited technically by resectoscope size, a problem 
overcome by the use of laser ablation if available, where a small diameter fiber is 
employed 14. 
 
If primary ablation is not possible, temporary urinary diversion is achieved by 
vesicostomy, ureterostomy or nephrostomy, with valve ablation later when the urethra 
can accommodate the resectoscope. Some centers advocate diversion procedures for 
patients whose renal function has not improved despite catheterization 15, 16. High 
diversion procedures may complicate with ureteric stricture formation and worse bladder 
capacity due to non-cycling of the bladder17. Vesicostomy, on the other hand, may result 
in a small capacity hyperreflexic bladder when compared to primary valve ablation 18. 
The timing of urodynamic testing after surgery is important, as bladder compliance may 
change with time. 
            
 Although the obstruction is easily corrected, the effects of pressure on both upper and  
lower renal tract may be permanent. The term valve- bladder syndrome describes 
persistent hydroureteronephrosis after valve ablation 19. Patients present with urinary 
incontinence due to bladder dysfunction, often worsened by nephrogenic diabetes 
insipidus with large volumes of dilute urine. The urodynamic findings include bladder 
hypertonia, detrusor hyperreflexia and/ or myogenic failure 20.   
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 1.4 Renal outcome  
Although antenatal diagnosis has improved mortality, the long term renal outcome 
remains poor, with as many as 30% of patients progressing to renal failure 11.  
 
To improve this outcome, many studies have attempted to identify good prognostic 
features and optimal surgical treatment. There seems to be no dispute that low serum 
creatinine after intervention carries a good renal prognosis 16, 21- 23, or that bladder 
dysfunction may be associated with poor long-term renal outcome 24, 25. However, there 
has been conflicting results regarding age at presentation 23, 26, 27,  pressure “pop-off” 
mechanisms such as unilateral VUR, ascites and bladder trabeculation 11, 28- 31 , and type 
of surgical intervention 32- 35.   
 
1.5 Somatic growth 
Poor somatic growth has been associated with increased mortality 36. Somatic growth in 
children with PUV may be affected by many factors, including: 
 Nutrition, which depends on both food availability and appetite 37- 39 
 Renal dysfunction 37, 40 , with associated abnormalities of parathyroid 
hormone (PTH) 41 , and metabolic acidosis 42  
 The presence of VUR 35 
 Type of surgery performed 43 and 
 Renal salt wasting 44. 
 
Although the measurement of growth in children is standard, the interpretation in 
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 children with renal dysfunction is difficult 45. Using length to monitor growth is a more 
sensitive marker in children with renal failure 37. In a child with fluid overload due to 
renal failure, weight may overestimate growth. 
 
1.6 Aims of the study. 
A twenty- one year follow-up of patients with posterior urethral valves enabled a 
descriptive study of the following parameters: 
a) Age at presentation 
b) The proportion of antenatal diagnoses  
c) Clinical presentation  
d) Radiological findings 
e) Mortality 
f) Renal outcome 
g)         Factors affecting renal outcome, specifically age at presentation, ascites and                                        
            VURD. 
 
In addition, this study compared the outcomes of boys treated with primary valve ablation 
versus vesicostomy with respect to the following parameters: 
1) Glomerular filtration rate (GFR), calculated using the Schwartz formula 46 
2) Growth, using z-scores for weight and height/ length. 
 
The outcome of PUV in black South African children has not been documented before. 
Primary valve ablation is the surgery of choice, but only possible if a small resectoscope 
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 is available. If not, a vesicostomy is performed with valve ablation at a later stage when 
the urethra can accommodate the available resectoscope. 
 
Since the choice of surgery depended entirely on the availability of a suitable 
resectoscope and not on the state of the upper renal tract or renal function, this study 
population provided a unique opportunity to compare growth and renal outcome in 
patients with similar renal status who had different surgical treatments. 
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                                                        CHAPTER 2 
 
2.1 Ethics clearance 
Ethics clearance was obtained from the Human Research and Ethics Committee of the 
University of the Witwatersrand; clearance number M070206 (appendix A). 
 
2.2 Study design and sample  
This was a retrospective record review of patients diagnosed with PUV and followed-up 
by the paediatric renal unit from January 1985 to December 2005 at Chris Hani 
Baragwanath Hospital. This is a large teaching hospital attached to the University of the 
Witwatersrand providing primary, secondary, tertiary and quaternary care to the people 
of Gauteng and to patients referred from other provinces and African countries. Records 
of all patients diagnosed with PUV during the study period were retrieved from the renal 
clinic filing system. Data was collected as per data sheet (appendix B). Patients were 
divided into four groups depending on their age at presentation: 
• Group 1: age less than one month 
• Group 2: age one month to twelve months 
• Group 3: age more than twelve months to sixty months 
• Group 4: age more than sixty months. 
 
For comparative analysis of surgery, patients were categorized into a primary valve 
ablation group and a vesicostomy group.  
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 Visits were defined as follows: 
1. initial visit: at presentation to hospital 
2. post- surgery visit: approximately 6 months post initial surgery 
3. final visit: last visit documented in the renal file before 31 December 2005. 
 
2.3 Diagnosis of PUV 
Posterior urethral valves were diagnosed either with VCU or cystoscopy. The presence of 
secondary VUR on VCU was graded using the International Reflux Study Group grading 
system 47. Also, most patients had abdominal ultrasound examinations as an initial 
investigation, where the presence or absence of hydronephrosis and ascites was 
documented. 
 
2.4 Renal function and serum electrolytes 
Serum creatinine was measured by the National Health Laboratory System (NHLS) using 
a Roche Hitachi automated clinical chemistry analyzer. This system uses the modified 
Jaffe reaction and is a kinetic in vitro test. The GFR was calculated using the formula 46, 
GFR= k x length (cm) x 88.5 / serum creatinine (umol/l), where k is an age and sex 
specific constant; k= 0.33 for low birth weight infants, k= 0.45 for infants less than 1year, 
k= 0.55 for children up to 12 years, and k= 0.70 for boys older than 12 years of age. This 
calculated GFR value was compared to age- appropriate tables of mean GFR to classify 
renal function as normal or decreased 48. In six records where patient height was not 
available, the expected height for age was used to calculate GFR.  Although the estimated 
GFR may have been falsely raised in these patients, the calculated GFR is preferred to 
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 serum creatinine as a marker of renal function since it includes patient height and gender 
in the equation. The calculated GFR at final visit was categorized into five stages using 
the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical 
Practice Guidelines for the Classification of Chronic Kidney Disease 49. 
  
In addition, most patients had radioisotope 99m Technetium dimercaptosuccinic acid 
(DMSA) scans performed to assess differential kidney function, the results of which were 
useful in deciding on nephrectomy for patients who had severe VUR in a non- 
functioning kidney and recurrent pyelonephritis. Valves with vesico-ureteric reflux and 
renal dysplasia (VURD) was defined as unilateral grade 4-5 VUR with ipsilateral renal 
dysplasia as evidenced by split function on DMSA scan of less than ten percent 29. 
 
Sodium in plasma or serum was determined by the NHLS electrochemically with a Na+ - 
ISE. Hyponatraemia was defined as a serum sodium concentration of less than 
130mmol/l 50.  Hypernatraemia was defined as a serum sodium concentration of more 
than 150mmol/l 51. 
 
Serum or plasma total carbon dioxide was determined by the NHLS enzymatically using 
phosphoenolpyruvate carboxylase on Roche automated clinical chemistry analyzers. The 
normal reference value for venous plasma or serum bicarbonate (HCO3-)  for children is 
22-29 mmol/l, and 20- 22 mmol/l for term newborns52 . Metabolic acidosis was defined 
as measured total carbon dioxide level of less than 20mmol/l.  
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  2.5 Somatic growth 
The weight in kilograms and height or length in centimeters was documented for each 
visit. Z-scores were calculated for weight for age and height/ length for age using epi-info 
anthropometric calculator, CDC 2000 growth charts 53.  
 
2.6 Statistical analysis 
All information was captured and analysed using epi- info version 2002. The analysis 
was confirmed using Stata statistical package. The students’ t-test was used to analyse 
quantitative variables. For categorical variables the chi- squared test was used. A p value 
of less than 0.05 was considered statistically significant. Regression analysis was used to 
find correlation factors for final GFR and somatic growth. 
 
2.7 Limitations of the study 
The following limitations of this retrospective study were anticipated: 
1. Neonates with severe obstruction and dysplastic kidneys may have demised 
before a diagnosis was established.  
2. Patients managed by urologists or surgeons may not have been referred to the 
renal service if they had normal renal function at presentation.  
3. Some data may be missing if not documented by the attending paediatrician. 
4. Measurement of weight and height/ length was not standardized. 
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                                                     CHAPTER 3 
 
3.0 Results 
A total of 128 patients were identified. All patients were of African descent. Eight 
records were excluded from analysis (3 refused consent to surgery, 3 had upper tract 
diversion, and 2 files could not be traced).  
 
3.1 Population parameters  
Figure 2 shows the percentage of patients in each of the 4 age groups at presentation. 
6%
19%
33%
42% <1 month
1- 12 months
>12 - 60 months
>60 months
 
Figure 2:  Age groups at presentation 
 
Ninety patients (75%) presented in the first year of life; 42% as neonates and 33% aged 
1- 12 months. Thirty patients presented after the age of 12 months. The mean (range) age 
at presentation was 12.9 (0 to 139) months. The mean (range) duration of follow-up was 
42 (1 to 206) months. Seventy- eight patients (65%) were lost to follow- up, with a mean 
(range) duration of follow-up of 30.7 (1- 143) months. On average six new cases were 
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 diagnosed every year. There were 5 (4.2%) documented deaths during the study period.  
 
3.2 Clinical parameters 
UTI and voiding problems were the most frequent mode of presentation. Voiding 
problems included delayed urination in the newborn period, poor urinary stream, 
dribbling of urine, and crying on micturition. Laboratory abnormalities included acidosis 
and hyponatraemia. Acidosis persisted in 53% of patients at the final visit. Jaundice was 
the presenting symptom in 12% of neonates. In five patients PUV were suspected at an 
antenatal visit (Table 1).  
 
 n Total Percent  Organism n Percent 
 Acidosis 80 103 77.7 E coli 29 43.9 
 UTI 80 112 71.4 Klebsiella 15 22.7 
Voiding problems 55 101 54.5 Enterobacter 8 12.1 
Distended abdomen 45 98 45.9 Proteus 3 4.5 
Hyponatraemia 39 115 33.9 Morganella 1 1.5 
Ascites 22 114 19.3 Serratia 1 1.5 
Neonatal jaundice 6 50 12.0 A baumani 1 1.5 
Vomiting 9 120 7.5 S aureus 4 6.1 
Haematuria 7 120 5.8 E faecalis 2 3.0 
Seizures 7 120 5.8 Group B strep 1 1.5 
Antenatal diagnosis 5 120 4.2 C albicans 1 1.5 
 Total 66 100.0 
 
Table 1: Clinical findings at presentation.                                                    Table 2: UTI organisms 
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 Organisms were documented in 66 of 80 (83%) patients who presented with a UTI; 58 of 
the 66 organisms identified were gram negative bacilli (Table 2).  
 
Fifteen patients had abnormalities involving other systems, especially the urogenital and 
central nervous systems (Table 3).  The study was not powered to determine whether 
these abnormalities were more frequent in patients with PUV than in the general 
population. 
System affected n  Percent Condition 
Neurological 9 7.5 Spina bifida                                   1 
School failure                                8 
Urogenital 8 6.6 Cryptorchidism                             4 
Patent urachus                               2 
VUJ obstruction                            1 
Inguinal hernia                              1 
   
Cardiovascular 5 4.2 ASD                                              1 
DORV, PS                                    1 
Mitral valve cleft                          1 
Myocarditis                                   1 
VSD, PDA                                    1 
   
Gastro-intestinal 2 1.7 Anorectal malformation                1 
Delayed gastric emptying             1    
Total 24 20                                                     24 
 
Table 3: Co- morbid conditions 
(VUJ vesico-ureteric junction; ASD atrial septal defect; DORV double outlet right ventricle; PS pulmonary 
stenosis; VSD ventricular septal defect; PDA patent ductus arteriosus). 
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 3.3 Radiological parameters  
Abdominal ultrasound findings were available for 114 patients at presentation. 
Hydronephrosis was present in 102 (89.5%), bilateral in 94 and unilateral in 8. There was 
no hydronephrosis in 12 (10.5%) patients. Bladder abnormalities were not analysed. 
 
VCU findings were documented in 102 patients. VUR was demonstrated in 36% of 
patients, unilateral in 24% and bilateral in 12%. VURD was diagnosed in 6 of 102 
patients (5.8%). All 6 patients had nephrectomies performed.  
 
3.4 Surgical intervention.  
Fifty- three patients had primary valve ablation; mean (range) weight 9.4 (2.3- 41) kg, 
while vesicostomy was performed in 67 patients; mean (range) weight 3.6 (1.4- 12.2) kg. 
Younger patients were more likely to have a vesicostomy performed, p<0.001 (Table 4). 
This reflects the limited availability of small resectoscopes.  
 
 < 1 month 1-12months >12-60months > 60months Total 
Primary ablation 6 19 21 7 53 
Vesicostomy 44 21 2 0 67 
Total 50 40 23 7 120 
 
Table 4: type of surgery vs age at presentation 
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 3.5 Renal outcome 
Table 5 shows the calculated GFR at final visit in the study group. Thirty-seven percent 
of patients had renal failure (calculated GFR < 60ml/min/1.73m2) 49. Renal failure was 
present at last visit in 35% of patients who did not return for scheduled visits. Six patients 
(5%) were referred for renal transplantation. 
 
GFR (ml/min/1.73m2) n  Total (percent)  n  Lost  n  Died 
> 90 53 (44.2) 35 0 
60- 89 22 (18.3) 16 1 
30- 59 23 (19.2) 16 2 
15– 29 11 (9.2) 6 0 
< 15 11 (9.2) 5 2 
Total 120 (100) 78 5 
 
Table 5: CKD stage at final visit 
 
3.5.1 Factors affecting renal outcome  
 The effect of type of surgical procedure on GFR is best assessed in the neonatal group. 
This eliminates the confounding variables of age at presentation, kidney maturation, 
degree of obstruction and bladder dysfunction. Figure 3 shows the mean calculated GFR 
in the neonatal group at initial visit (p= 0.85), 6 months after the procedure (p= 0.67), and 
at final visit (p= 0.87) in the 2 surgical groups. There is no significant difference in final 
GFR for the surgical procedures. The mean (range) duration of follow-up in the neonatal  
group was 46.3 (1- 161) months. 
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 Neonatal group GFR vs surgery
0
10
20
30
40
50
60
70
80
90
mean GFR initial mean GFR 6mo mean GFR final
primary ablation
vesicostomy
 
Figure 3: Mean GFR vs type of surgery in neonates   
 
Linear regression analysis for all possible factors affecting final GFR was performed for 
the study group overall (Table 6) and for age groups 1 and 2 separately (Table 7). Group 
2 was analysed separately since patient numbers were similar for the two surgical 
procedures. Age at presentation, bilateral irregular uptake on DMSA scan, and initial and 
post- surgery GFR, had a statistical significant impact on final GFR for all age groups. 
However, in both the neonatal age group and group 2, only the GFR post- surgery was 
significantly associated with the final GFR. Of note, the type of surgery performed, 
presence of ascites or VURD, and antenatal diagnosis did not impact on final GFR. Using 
multiple regression analysis, only GFR post- surgery was statistically significant. A 
scatter plot for final GFR was determined (figure 4). 
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    Variable 
       Overall,     n= 120 
co-efficient r2 p- value 
Antenatal diagnosis -19.46 0.01 0.45 
Age in months 1.04 0.12 0.004 
Ascites -24.35 0.05 0.42 
DMSA irregular uptake  -33.38 0.11 0.03 
GFR initial 0.75 0.25 0.0001 
GFR 6months post surgery 0.72 0.40 0.00001 
Surgery -11.23 0.01 0.36 
VUR -29.68 0.03 0.28 
VURD -40.0 0.02 0.27 
 
Table 6: Linear regression analysis for final GFR in group overall. 
 
Variable       Neonatal group ,    n= 50 Age group 2 , n= 40 
 co-efficient r2 p- value co-efficient r2 p- value 
Antenatal diagnosis -5.96 0.00 0.79 no antenatal diagnoses 
Age in months 17.61 0.02 0.477 3.46 0.04 0.4 
Ascites 31.68 0.07 0.18 -37.25 0.07 0.56 
DMSA irregular uptake  25.62 0.08 0.28 -44.75 0.16 0.24 
GFR initial 1.345 0.08 0.167 0.64 0.20 0.055 
GFR 6months post surgery 1.095 0.44 0.0001 0.96 0.44 0.005 
Surgery 4.99 0.00 0.800 -1.20 0.00 0.963 
VUR -23.05 0.04 0.358 74.11 0.12 0.24 
VURD Unable to do, only 1 value -33 0.02 0.63 
 
Table 7: Linear regression analysis for final GFR in age groups 1 and 2 
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Figure 4: scatter plot for final GFR and GFR post surgery 
 
Late age at presentation was associated with better initial and final GFR (figure 5).  
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Figure 5: Mean GFR vs age at presentation 
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 Patients who had normal serum sodium at presentation were more likely to have normal 
renal function at final visit, p = 0.035 (table 8). 
 CKD STAGE 
serum sodium 1 GFR>90 2 GFR 60-89 3 GFR 30-59 4 GFR 15-29 5 GFR <15 TOTAL 
decreased 
Row % 
Col % 
9 
23.1 
18.0 
10
25.6
45.5
8
20.5
36.4
5
12.8
50.0
7
17.9
63.6
39 
100.0 
33.9 
increased 
Row % 
Col % 
1 
33.3 
2.0 
1
33.3
4.5
0
0.0
0.0
1
33.3
10.0
0
0.0
0.0
3 
100.0 
2.6 
normal 
Row % 
Col % 
40 
54.8 
80.0 
11
15.1
50.0
14
19.2
63.6
4
5.5
40.0
4
5.5
36.4
73 
100.0 
63.5 
TOTAL 
Row % 
Col % 
50 
43.5 
100.0 
22
19.1
100.0
22
19.1
100.0
10
8.7
100.0
11
9.6
100.0
115 
100.0 
100.0 
 
 
 
 
 
 
 
Table 8: CKD stage vs serum sodium 
 
3.6 Somatic growth   
The following factors correlated with final height in all age groups (table 9): GFR at all 
study visits, initial and post- surgery z- scores for length, and bilateral irregular uptake on 
DMSA scan. In the neonatal group however, only 3 variables were significant: GFR at 6 
months post surgery, final GFR, and z-score for length at 6 months post surgery. The age 
at presentation, type of surgery, and acidosis did not affect the final height. 
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Variable 
Overall,         n= 120 Neonatal group,    n= 50 
Co-efficient r2 p- value Co-efficient r2 p- value 
Acidosis initial -0.77 0.05 0.26 0.677 0.08 0.626 
Acidosis 6mo 0.36 0.12 0.53 0.548 0.08 0.54 
Acidosis final -0.49 0.06 0.56 2.106 0.18 0.016 
Age in months 0.02 0.04 0.07 2.08 0.09 0.08 
GFR initial 0.01 0.09 0.01 0.044 0.04 0.325 
GFR 6mo 0.02 0.25 0.00003 0.046 0.34 0.001 
GFR final 0.027 0.48 0.0001 0.037 0.47 0.000023 
Irregular uptake DMSA  1.73 0.15 0.04 2.185 0.18 0.06 
Surgery -0.57 0.02 0.17 -1.231 0.05 0.219 
VURD -0.125 0.00 0.89 Unable to do, only 1 value 
z- score length 6months 0.69 0.42 0.001 0.66 0.39 0.000095 
z- score length initial 0.25 0.08 0.01 0.266 0.06 0.23 
 
Table 9: Linear regression analysis for final length z- score  
 
 
Similarly, table 10 shows the variables affecting final weight z- scores. For the overall 
group these include acidosis at final visit, age at presentation, GFR at all study visits, type 
of surgery, and initial and 6 months post- surgery z- scores for weight. For the neonatal 
group only 4 variables remained significant: acidosis at final visit, GFR after surgery, 
final GFR, and post surgery z-score for weight. Using stepwise regression analysis, only 
the initial and post- surgery z-scores for weight, and acidosis at final visit correlated with 
final weight z- scores. 
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 Variable Overall,         n= 120 Neonatal group,   n= 50 
co-efficient r2 p- value co-efficient r2 p- value 
Acidosis final visit 1.3 0.11 0.004 2.365 0.24 0.0051 
Age months 0.025 0.06 0.029 1.364 0.04 0.243 
GFR initial 0.01 0.07 0.027 0.053 0.05 0.255 
GFR 6 months 0.023 0.23 0.000053 0.048 0.39 0.00242 
GFR final 0.024 0.38 0.000001 0.036 0.46 0.00002 
DMSA irregular uptake 0.713 0.12 0.102 1.730 0.16 0.116 
Surgery -0.962 0.06 0.023 -1.505 0.07 0.125 
VURD 0.280 0.0012 0.776 Only 1 value, unable to do 
z- score weight initial  0.28 0.05 0.047 0.252 0.01 0.515 
z-score weight 6month 0.72 0.50 0.0001 0.72 0.44 0.00001 
 
Table 10: linear regression analysis for final weight z-score.  
 
 
3.6.1 Age at presentation  
The initial mean z-score for length and weight was relatively better in the neonatal group 
(figure 6 & 7), possibly reflecting adequate placental function as a determinant of fetal 
growth. The mean z-scores for length and weight then deteriorated at subsequent visits in 
this group. This could be due to a combination of factors, including renal dysplasia, 
acidosis and malnutrition. In all other age groups the mean z- scores for length and 
weight improved with time after intervention. Young age at presentation was associated 
with a less favourable final weight and height z- score.         .    
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Figure 6: mean length z- score vs age at presentation. 
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Figure 7: mean weight z- score vs age at presentation. 
 
3.6.2 Type of surgery 
Figure 8 shows the impact of type of surgery on mean length z- scores for all age groups. 
There was no statistical significant difference in z- scores in the 2 surgical groups, but the 
primary ablation group showed some improvement in mean z- scores for length. This 
different outcome was not reflected in the analysis of the neonatal group (figure 9). 
Analyses of the neonatal group eliminates the confounding variables of age at 
presentation and degree of obstruction. 
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Figure 8: Overall mean z-score for length vs type of surgery   
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Figure 9: Neonatal group mean z-score for length vs type of surgery  
 
Figure 10 shows the mean z- scores for weight in the 2 surgical groups. Overall, the final 
mean z-score for weight was significantly better in the primary valve ablation group,  
p = 0.0014. This did not reach significance in the neonatal group (figure 11).  
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Figure 11: Neonatal mean z-scores for weight vs type of surgery 
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                                              CHAPTER 4 
 
4.1 Descriptive analysis 
The results of the descriptive data are typical of a developing country 32, 54, 55. 
The antenatal detection rate is low compared to the developed world; less than 5% of this 
cohort had antenatal detection compared to 41% in other reports 56. Screening antenatal 
ultrasound examinations are not offered routinely to patients at Chris Hani Baragwanath 
Hospital or at the primary care maternity clinics attached to the hospital. Suboptimal staff 
to patient ratios limits this as an option. The mean age at presentation is one year of age, 
reflecting the low rate of antenatal detection. However, most patients were diagnosed 
with PUV within the first year of life. 
 
A large proportion of patients do not return for scheduled clinic visits, especially after 
definitive surgery has been performed. This is concerning especially since some patients 
will progress to renal failure due to valve bladder syndrome, recurrent UTI, reflux 
nephropathy and hyperfiltration injury 15, 20, 21. 
 
The mortality appears low (5 deaths), but this is not representative since 43 patients who 
did not return for scheduled visits had reduced GFR. It is possible that some of these 
patients died at home or in other centres. 
 
The clinical presentation of this group of patients is similar to other reports, with UTI and 
voiding problems the most common mode of presentation. Metabolic acidosis persisted in  
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 more than half of the patients at last visit. The metabolic acidosis was not related to 
worsening GFR. This probably reflects a renal tubular acidosis. Patients are treated with 
sodium bicarbonate routinely if this is diagnosed. Poor adherence to medication or 
inadequate dosing could explain this finding.  
 
Neonates commonly present with jaundice and/ or seizures. This could be a result of 
underlying urosepsis, electrolyte and metabolic derangements, and renal failure. A urine 
dipstix and culture is mandatory in such patients. 
 
Abnormalities of other organ systems are frequent in this group of patients, especially 
involving the urogenital and neurological system. Whether this is more frequent than in 
the general population cannot be confirmed, but it could be in keeping with a congenital 
abnormality 13. Patients should be screened for abnormalities in other systems. School 
failure is a common co- morbid condition and should be enquired about with appropriate 
referral for assessment. It is possible that school failure is a result of brain involvement as 
part of a congenital abnormality, or due to seizures, sodium abnormalities and/ or 
uraemia during the period of brain development, or due to poor self- esteem associated 
with urinary incontinence. 
  
Hydronephrosis on abdominal ultrasound is not universal in patients with PUV; in this 
study hydronephrosis is absent in 10.5% of patients. In other studies hydronephrosis was 
documented in 47% to 80% of patients at presentation 9, 33, 55. This could be explained by 
the theory that PUV has a spectrum of obstruction, and only cases with severe obstruction  
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 results in back pressure, VUR or relative vesico-ureteric junction obstruction due to a 
hypertrophied bladder. It is also possible that bladder catheterization drains the 
hydronephrosis so that this finding is not noticeable at the time of ultrasonography 19. 
Krueger et al demonstrated hydronephrosis using intravenous pyelogram (IVP) in all 
their patients with PUV 43. IVP is not routinely used in paediatric patients due to the risk 
of contrast and radiation exposure. It is possible that IVP is more sensitive than 
ultrasound in the detection of hydronephrosis. Also, although some ultrasound 
examinations are performed by sonographers and junior registrars, these are supervised 
and probably do not explain the cases without hydronephrosis.  It is worth noting that this 
cohort had PUV diagnosed with VCU and/ or cystoscopy. The results of this analysis 
suggest that a normal abdominal ultrasound in a boy does not exclude the diagnosis of 
PUV in our population, and a VCU should be considered if a UTI is diagnosed in a boy. 
 
VUR was demonstrated in 36% of patients at presentation. The frequency of VUR ranged 
from 16% to 80% in the literature reviewed 9, 11, 18, 21, 22, 24- 26, 29 . Where catheterization of 
the bladder was not possible, a retrograde urethrogram was performed; this may 
underestimate the true frequency of VUR in this study population.  
 
4.2 Comparative analysis 
 
4.2.1 Renal outcome 
The renal outcome is similar to reports from developed countries 11. Thirty- seven  
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 percent of patients have renal failure (GFR < 60ml/min/1.73m2) at the final visit.  
 
4.2.2 Renal protective factors 
Overall, age at presentation was significantly associated with renal outcome, with older 
children having a relatively better calculated GFR at both the initial and final visits. 
Reports of poor renal survival in children who present before one year of age has been 
published before 23.  This is in contrast to other studies 26, 27 where late presentation 
resulted in a worse renal outcome. However, the late presentation group reported by El- 
Sherbiny et al 27 had more hydroureteronephrosis than the younger group, a confounding 
factor that may reflect valve bladder syndrome and its associated progression to renal 
failure. Ziylan et al 26 compared late presentation to a group who presented before age 5 
years and found worse renal outcome in the late presentation group. Perhaps if they 
selected the young age group to include only children less than one year of age their 
findings would have been different. Older children may represent milder forms of 
obstruction. Late age at presentation should not be confused with delay in diagnosis. 
 
VURD and ascites have been reported to offer protection against renal failure since it 
allows pressure pop-off mechanisms 28- 30.  This was not demonstrated in this analysis. 
However, numbers were small for VURD. Only six patients in this study population had 
VURD diagnosed, but ascites was documented in 22 (19.3%) patients.  Other studies 
could also not demonstrate renal protection by VURD 11, 56.  In addition, scarring in the  
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 contralateral kidney has been documented on DMSA scan 57. This carries with it the 
long- term risk of hypertension and renal failure.  
 
The type of surgery performed and its impact on renal outcome was similarly assessed 
by others 33- 35. Like this study, they demonstrated no difference in renal outcome for 
vesicostomy or primary valve ablation.  
 
This study demonstrated a significant association between normal serum sodium at 
presentation and normal final renal function in 51 patients compared to 22 patients with 
normal serum sodium and renal failure. However, the reverse is not true. Of the 39 
patients who had hyponatraemia, 19 had a calculated GFR > 60ml/min/1.73m2 and 20 
had renal failure (GFR <60ml/min/1.73m2). 
  
The post surgery GFR correlated well with the final GFR. A scatter plot was determined. 
This has been shown previously in other studies 11, 16, 23. The creatinine at presentation 
should not be used to prognosticate renal outcome. 
 
In summary: late age at presentation, normal GFR after surgery, and normal serum 
sodium at initial visit were favourable prognostic factors.  The type of surgery performed 
and the presence of pressure pop- off mechanisms did not influence renal outcome. 
 
4.2.3 Somatic growth      
The following factors were associated with poor somatic growth in this study population: 
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 • Acidosis at last visit. This was associated with poor final z-score for weight but 
not for length. The acidosis was not related to renal failure and uraemia. It 
probably reflects a renal tubular acidosis. This has been described before in 
children with obstructive uropathy 21. Acidosis limits growth due to non- pulsatile 
secretion of growth hormone 42. 
•  Age at presentation. Children who presented after the age of 12 months had 
relatively better initial and final z- scores for length. Similar findings were 
reported by Krueger et al 43 and Drozdz  et al 23. This is in keeping with previous 
suggestions that this group of children represents a milder form of obstruction. 
This late age at presentation should not be confused with delayed diagnosis of 
PUV.  
• GFR at all study visits. Renal failure was associated with poor growth in this 
study population. Multiple factors may be responsible for this, including poor 
appetite, acidosis, anaemia, and uraemic gastritis 35, 37, 40. 
• Irregular uptake on DMSA scan of both kidneys affected the final z- score for 
length in this study. Narasimhan et al 57 reported no difference in growth rate for 
children with and without renal scarring on DMSA scan. However, their group 
included patients with unilateral scarring only. It is possible that scarring 
involving only one kidney may not limit somatic growth to the extent that 
bilateral scarring does. 
• Weight and height z- scores at all study visits correlated with the final z- scores 
for weight and height. This is not unexpected.  
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 • Type of surgery. Overall, children in the primary valve ablation group had 
significantly better final z- scores for weight than children in the vesicostomy 
group. However, the confounding factors are that the vesicostomy patients were 
smaller and younger, and may reflect a group with more severe obstruction and 
immature renal function. There was no difference in final z- scores for weight                             
when type of surgery was compared in the neonatal group. The mean z- scores for 
weight and length improved in all groups after surgical and medical intervention. 
Krueger et al 43 showed a remarkable improvement in growth in a group of 
neonatal boys who had supravesical diversion compared to those with primary 
valve ablation, even though the former group had worse initial serum creatinine. 
They postulate that supravesical diversion allows greater preservation of nephron 
function. Their data however, does not include statistical analysis, so although 
they may show trends of improved growth in the supravesical diversion group, the 
statistical significance of this has not been proven. In this report, patients who had 
supravesical diversion procedures were excluded from analysis, so it is not 
possible to confirm or refute those findings.    
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                                                       CHAPTER 5 
 
5.0 Conclusion 
PUV is common in this population with on average 6 new cases diagnosed per year. This 
is probably an underestimate for reasons discussed in Chapter 2.6.  The population 
parameters are typical of a developing country, with low antenatal detection rates and 
poor adherence to scheduled outpatient visits.  
 
The renal outcome in this study population is similar to reports from developed 
countries, with a calculated GFR < 60ml/min/1.73m2 at final visit in 37% of patients.  
The calculated GFR after relief of obstruction correlates well with the final calculated 
GFR. The presence of VURD or ascites offers no protection in renal outcome in this 
group of patients.  Young age at presentation is associated with poor renal outcome. 
Type of surgery performed does not impact on renal outcome. However, the effect on 
bladder function needs to be assessed.  
 
In this study, factors that correlate with poor somatic growth in boys with PUV include 
acidosis at final visit, young age at presentation, poor renal function, bilateral irregular 
uptake on DMSA scan, and initial and post surgery weight and height. There is no 
difference in final weight and height z- scores with primary valve ablation or 
vesicostomy.  
 
South African children have additional disadvantages that limit optimal growth.  
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  Malnutrition is common with a low birth weight rate of 15% and stunting in 21% of            
children younger than 10 years old 58. Infectious diseases, especially the human 
immunodeficiency virus (HIV) and tuberculosis (TB), are common causes of poor 
growth. These problems were not explored in this report. 
 
5.1 Recommendations  
 Antenatal detection rates need to improve. This may prove difficult in a resource- 
constrained setting, but the problem should be highlighted and early antenatal clinic 
visits encouraged to create the opportunity for antenatal screening.  
 Parents need to be educated about the long term risk of renal deterioration to improve 
adherence to scheduled clinic visits. 
 Contrary to National Institute of Health Clinical Excellence (NICE) guidelines 59, a 
sonar of the kidneys and bladder is recommended for every patient diagnosed with a 
UTI since antenatal detection rates are low. A VCU should be considered even if the 
abdominal sonar is normal. 
 Small caliber resectoscopes should be made available since only one operation is 
necessary for primary valve ablation. 
 Bladder function should be assessed and appropriately managed to prevent 
deterioration in renal function over time.  
 Strict attention should be paid to UTI prophylaxis and treatment, correction of 
metabolic acidosis, and renal function in boys with PUV. 
 All boys diagnosed with posterior urethral valves should be referred to specialist 
nephrology units for management and long term follow-up. 
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 APPENDIX A                          Ethics clearance certificate 
   
 APPENDIX B                           Data collection sheet 
 
 Record number _______                Initials____                   Date of birth______                      
Year____           
 Age (months) at initial presentation   _____                                       
 Age group   1    2     3      4 
Antenatal diagnosis yes/ no 
 
Features at presentation       urinary tract infection yes/ no         organism _____________ 
                                       obstruction yes/ no           (dribbling, poor urinary stream) 
                                       abdominal distension    
                                       serum sodium  decreased /  normal / increased 
                                       other _________________________________      
 
date 1(presentation)                  date 2  (6 months post surgery)         date 3 (final) 
_________________                _________________                         _________________ 
weight 1(kg)   _____                weight 2 __________                         weight 3_________ 
z-score weight 1  __                 z-score weight 2 ___                           z-score weight3 ___ 
length 1 (cm) _____                  length 2 __________                         length 3 _________ 
z-score length 1 ___                  z-score length 2____                         z-score length 3 ___ 
creatinine 1 (umol/l)  ___          creatinine 2 _______                         creatinine 3 ______ 
GFR 1 __________                   GFR 2 ___________                        GFR 3 __________ 
acidosis 1    yes/ no                    acidosis 2 yes/ no                             acidosis 3 yes/ no 
 35
 Ascites   yes/ no 
Hydronephrosis :      none     left     right     bilateral   
VUR       none     left      right      bilateral                 Grade left_____  Grade right____ 
DMSA   scarring          none     left      right     bilateral  
                     Relative function       left _____%                            right _____%  
VURD    yes/ no 
 
Surgery     primary valve ablation / vesicostomy                        Surgery date 
Renal outcome CKD stage_____                                Referred for renal transplant yes/ no 
Duration of follow-up (months)  ________                 Lost to follow- up   yes/ no             
Death   yes/ no                   date of death ___________ 
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